Photothermal Ferrotherapy – Induced Immunogenic Cell Death via Iron‐Based Ternary Chalcogenide Nanoparticles Against Triple‐Negative Breast Cancer
Small · 2024
DOI: 10.1002/smll.202306766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Qiang Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Iron, Nanoparticles, Photothermal Therapy. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Science, Technology and Innovation Commission of Shenzhen Municipality, Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Triple‐negative breast cancer (TNBC) is highly malignant and prone to recurrence and metastasis. Patients with TNBC have limited therapeutic options, often resulting in poor prognosis. Some new treatments for TNBC have been considered in the past decade, such as immunotherapy, photothermal therapy (PTT), and ferroptosis therapy, that allow the rapid and minimally invasive ablation of cancer. However, a multifunctional nanodrug system with more potent efficacy for TNBC is still needed. The use of iron‐based ternary chalcogenide nanoparticles (NPs), namely AgFeS 2 , is reported, which synergistically combines photothermal therapy, ferrotherapy, and immunotherapy in one system for the treatment of TNBC. AgFeS 2 possesses excellent photothermal conversion performance for tumor near‐infrared (NIR) phototherapy. Upon photoirradiation, these NPs generate heat, accelerate the release of iron ions, and effectively catalyze the Fenton reaction, resulting in cell apoptosis and ferroptosis. Additionally, AgFeS 2 promotes the release of tumor‐specific antigens and triggers an immune response via immunogenic cell death (ICD), thereby providing unique synergistic mechanisms for cancer therapy. The present study demonstrates the great potential of iron‐based ternary chalcogenide as a new therapeutic platform for a combination of photothermal therapy, ferrotherapy, and immunotherapy for the suppression of TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China.
- Department of Gastrointestinopancreatic Surgery, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
- Department of Materials, Imperial College London, London, SW7 2AZ, UK.
- Shenzhen Key Laboratory of Chinese Medicine Active Substance Screening and Translational Research, Shenzhen, 518107, China.
- ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, China.
ORCID-Profile: Danyang Li
Förderung
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Wu, Q., Li, Z., Zhou, X., Wei, Z., Ramadan, S., Xu, Y., Xu, L., & Li, D. (2024). Photothermal Ferrotherapy – Induced Immunogenic Cell Death via Iron‐Based Ternary Chalcogenide Nanoparticles Against Triple‐Negative Breast Cancer. Small. https://doi.org/10.1002/smll.202306766
Vancouver
Wu Q, Li Z, Zhou X, Wei Z, Ramadan S, Xu Y, et al. Photothermal Ferrotherapy – Induced Immunogenic Cell Death via Iron‐Based Ternary Chalcogenide Nanoparticles Against Triple‐Negative Breast Cancer. Small. 2024. doi:10.1002/smll.202306766
BibTeX
@article{Wu2024,
author = {Wu, Qiang and Li, Zhuoyuan and Zhou, Xin and Wei, Zhewei and Ramadan, Sami and Xu, Yunsheng and Xu, Lizhou and Li, Danyang},
title = {Photothermal Ferrotherapy – Induced Immunogenic Cell Death via Iron‐Based Ternary Chalcogenide Nanoparticles Against Triple‐Negative Breast Cancer},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202306766}
}
EUVIMED